Metal–Phenolic Nanomedicines Targeting Fatty Acid Metabolic Reprogramming to Overcome Immunosuppression in Radiometabolic Cancer Therapy
ACS Applied Materials & Interfaces · 2025
DOI: 10.1021/acsami.4c21028 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Guohao Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Xiamen Cell Therapy Research Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361003, China. Hauptthemen laut MEDLINE: Fatty Acids, Neoplasms, Coordination Complexes. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade de Macau, Natural Science Foundation of Xiamen Municipality, Fujian Provincial Health Technology Project.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Xiamen Cell Therapy Research Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361003, China.
- Department of Public Health and Medical Technology, Xiamen Medical College, Xiamen 361023, China.
- Center for Precision Medicine, The First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen361000, China.
- Department of Laboratory Medicine, The First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen361000, China.
- Department of Cardiology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361003, China.
- Department of Neurosurgery and Department of Neuroscience, Fujian Key Laboratory of Brain Tumors Diagnosis and Precision Treatment, Xiamen Key Laboratory of Brain Center, the First Affiliated Hospital of Xiamen Universi…
ORCID-Profile: Yunlu Dai
Förderung
- Universidade de Macau
- Natural Science Foundation of Xiamen Municipality
- Fujian Provincial Health Technology Project
- Fundo para o Desenvolvimento das Ci?ncias e da Tecnologia
- National Natural Science Foundation of China
- Xiamen Cell Therapy Research Center
- Xiamen City
Zitieren
APA
Wang, G., Wang, D., Xia, L., Lian, J., Zhang, Q., Shen, D., Wang, Z., & Dai, Y. (2025). Metal–Phenolic Nanomedicines Targeting Fatty Acid Metabolic Reprogramming to Overcome Immunosuppression in Radiometabolic Cancer Therapy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c21028
Vancouver
Wang G, Wang D, Xia L, Lian J, Zhang Q, Shen D, et al. Metal–Phenolic Nanomedicines Targeting Fatty Acid Metabolic Reprogramming to Overcome Immunosuppression in Radiometabolic Cancer Therapy. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.4c21028
BibTeX
@article{Wang2025,
author = {Wang, Guohao and Wang, Dongmei and Xia, Lu and Lian, Jiabian and Zhang, Qing and Shen, Dongyan and Wang, Zhanxiang and Dai, Yunlu},
title = {Metal–Phenolic Nanomedicines Targeting Fatty Acid Metabolic Reprogramming to Overcome Immunosuppression in Radiometabolic Cancer Therapy},
journal = {ACS Applied Materials & Interfaces},
year = {2025},
doi = {10.1021/acsami.4c21028}
}
EUVIMED